Recalls / Active ingredient / Cytarabine
Cytarabine
1 FDA drug recall involving the active ingredient “Cytarabine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2012-06-27 | Class II | Cytarabine Injection, 20 mg/mL, 50 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured | Hospira Inc. |